ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2101

UV-Induced Skin Inflammation Is Exacerbated in Lupus-Prone Ro60 Knockout Female Mice with Interferon Priming

Masaoki Kawasumi1, Daiki Rokunohe1, Xizhang Sun2, Lena Tanaka2, Sladjana Skopelja-Gardner3, Edward Chiou2, Anne Davidson4, Sandra L. Wolin5 and Keith B. Elkon2, 1Medicine/Dermatology, University of Washington, Seattle, WA, 2Medicine/Rheumatology, University of Washington, Seattle, WA, 3University of Washington, Seattle, WA, 4Feinstein Institute for Medical Research, Manhasset, NY, 5National Cancer Institute, Frederick, MD

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Inflammation, Interferons and skin, RNA, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Lupus Erythematosus – Animal Models Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Photosensitivity is a major symptom of lupus, and excessive sunlight can cause skin rashes and flares of disease activity in systemic lupus erythematosus (SLE). Although UV-induced skin inflammation has been widely studied, it remains elusive how UV triggers lupus. A previous study demonstrated that mice lacking the Ro60 autoantigen (Ro60–/–) have increased photosensitivity and spontaneously develop lupus after 6 months of age. Also, it has been shown that lupus patients have elevated levels of type I interferon (IFN). To dissect molecular mechanisms by which UV-induced inflammatory responses are exacerbated in lupus, we combined IFN priming with photosensitive Ro60–/– mice and investigated the effects of UV on lupus-prone skin.

Methods: A recombinant adenovirus encoding IFN-alpha was administered to 4–5-month-old mice by retro-orbital injection two weeks prior to UV irradiation (IFN priming). Subsequently, mice were irradiated with UVB 250 mJ/cm2/day for three consecutive days. Skin biopsies were taken at four time points and subjected to histological, flow cytometry, and gene expression analyses. Eight groups (n = 4 mice per group) were compared: wild type (WT) versus Ro60–/– (C57BL/6 background), male versus female, and with or without IFN priming.

Results: Three consecutive UV exposures caused severe skin damage (erythema and hyperkeratosis) in IFN-primed Ro60–/– females. Gene expression analysis of UV-irradiated skin revealed that many inflammatory genes were differentially upregulated among the 8 mouse groups. Specifically, a combination of IFN priming, Ro60 deficiency, and female gender augmented UV-induced upregulation of Irf7 (regulator of type I IFN gene induction), Isg15 (IFN-stimulated gene), and Ccl2 (chemokine for monocyte recruitment). Consistently, flow cytometry analysis revealed that more inflammatory monocytes (CD45+Ly6ChighLy6Glow) were recruited to UV-irradiated skin 1 day after the third UV in IFN-primed Ro60–/– females than in IFN-primed WT females. Intriguingly, IFN-primed Ro60–/– females exhibited significantly higher levels of Ifnar2 (IFN alpha receptor subunit 2) following UV than their WT counterparts, likely contributing to augmented type I IFN responses.

Conclusion: Inflammatory responses to UV irradiation were augmented in IFN-primed Ro60–/– female, but not in WT, male, or unprimed mice. This female predominance is comparable to that of SLE in humans. Ro60 is an RNA-binding protein and binds to small noncoding RNAs. Lack of Ro60 may disrupt RNA homeostasis and activate RNA sensors and type I IFN pathways. This study provides novel insight into lupus susceptibility factors (IFN priming, Ro60 deficiency, and female gender) that contribute to exacerbation of UV-induced skin inflammation.


Disclosure: M. Kawasumi, None; D. Rokunohe, None; X. Sun, None; L. Tanaka, None; S. Skopelja-Gardner, None; E. Chiou, None; A. Davidson, None; S. L. Wolin, None; K. B. Elkon, None.

To cite this abstract in AMA style:

Kawasumi M, Rokunohe D, Sun X, Tanaka L, Skopelja-Gardner S, Chiou E, Davidson A, Wolin SL, Elkon KB. UV-Induced Skin Inflammation Is Exacerbated in Lupus-Prone Ro60 Knockout Female Mice with Interferon Priming [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/uv-induced-skin-inflammation-is-exacerbated-in-lupus-prone-ro60-knockout-female-mice-with-interferon-priming/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/uv-induced-skin-inflammation-is-exacerbated-in-lupus-prone-ro60-knockout-female-mice-with-interferon-priming/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology